CAROLE MATHELIN

Prof. Dr. CAROLE MATHELIN

ICANS
+1
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
CMCAROLE MATHELIN
CAROLE MATHELIN
SSSamuel Salvador
Samuel Salvador
DHDaniel Huss
Daniel Huss
JGJean-Louis Guyonnet
Jean-Louis Guyonnet
The aim of this study was to evaluate the ability of a prototype intraoperative mini γ-camera, the CarolIReS, with a 50 × 50 mm field of view, to precisely localize sentinel lymph nodes (SLNs) and to determine their depth in a series of patients with infiltrative breast cancer requiring SLN excision. Methods: With the use of phantoms, the broadness of the signal of an acquired projection was shown to linearly depend on its distance from the collimator. A preclinical ex vivo study of 25 excised SLNs demonstrated that SLN size did not influence depth estimation. The minimum activity threshold for successful use of the proposed method was determined. After a preoperative radioisotope injection and lymphoscintigraphy, the SLN was localized in a series of 11 patients using both the mini γ-camera and a γ-probe. During surgery, a ruler was used to measure the depth of all SLNs before their excision. Results: Using the measured linear dependence of image broadness, we found that the expected SLN anatomic depth was compatible with its measured depth during surgery. Conclusion: This study showed that the mini γ-camera efficiently estimated the location of SLNs in 3 dimensions.

Verified
Journal Article
Open access
PDF file
MBMorwenn Le Boulc’h
Morwenn Le Boulc’h
JGJulia Gilhodes
Julia Gilhodes
ZSzara steinmeyer
zara steinmeyer
SMSébastien Molière
Sébastien Molière
CMCAROLE MATHELIN
CAROLE MATHELIN
Background: This systematic review aimed at comparing performances of ultrasonography (US), magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography (PET) for axillary staging, with a focus on micro- or micrometastases. Methods: A search for relevant studies published between January 2002 and March 2018 was conducted in MEDLINE database. Study quality was assessed using the QUality Assessment of Diagnostic Accuracy Studies checklist. Sensitivity and specificity were meta-analyzed using a bivariate random effects approach; Results: Across 62 studies (n = 10,374 patients), sensitivity and specificity to detect metastatic ALN were, respectively, 51% (95% CI: 43–59%) and 100% (95% CI: 99–100%) for US, 83% (95% CI: 72–91%) and 85% (95% CI: 72–92%) for MRI, and 49% (95% CI: 39–59%) and 94% (95% CI: 91–96%) for PET. Interestingly, US detects a significant proportion of macrometastases (false negative rate was 0.28 (0.22, 0.34) for more than 2 metastatic ALN and 0.96 (0.86, 0.99) for micrometastases). In contrast, PET tends to detect a significant proportion of micrometastases (true positive rate = 0.41 (0.29, 0.54)). Data are not available for MRI. Conclusions: In comparison with MRI and PET Fluorodeoxyglucose (FDG), US is an effective technique for axillary triage, especially to detect high metastatic burden without upstaging majority of micrometastases.

7 April 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MZMehdi Zouiouich
Mehdi Zouiouich
TMThomas Di Mattia
Thomas Di Mattia
AMArthur Martinet
Arthur Martinet
JEJulie Eichler
Julie Eichler
CWCorinne Wendling
Corinne Wendling
FAFabien Alpy
Fabien Alpy
Membrane contact sites between organelles are organized by protein bridges. Among the components of these contacts, the VAP family comprises ER–anchored proteins, such as MOSPD2, that function as major ER–organelle tethers. MOSPD2 distinguishes itself from the other members of the VAP family by the presence of a CRAL-TRIO domain. In this study, we show that MOSPD2 forms ER–lipid droplet (LD) contacts, thanks to its CRAL-TRIO domain. MOSPD2 ensures the attachment of the ER to LDs through a direct protein–membrane interaction. The attachment mechanism involves an amphipathic helix that has an affinity for lipid packing defects present at the surface of LDs. Remarkably, the absence of MOSPD2 markedly disturbs the assembly of lipid droplets. These data show that MOSPD2, in addition to being a general ER receptor for inter-organelle contacts, possesses an additional tethering activity and is specifically implicated in the biology of LDs via its CRAL-TRIO domain.

1 December 2005 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
DBDavid Brasse
David Brasse
BHBernard Humbert
Bernard Humbert
CMCAROLE MATHELIN
CAROLE MATHELIN
MRMarie-Christine Rio
Marie-Christine Rio
JGJean-Louis Guyonnet
Jean-Louis Guyonnet
Recent developments in micro-CT have revolutionized the ability to examine in vivo living experimental animal models such as mouse with a spatial resolution less than 50 microm. The main requirements of in vivo imaging for biological researchers are a good spatial resolution, a low dose induced to the animal during the full examination and a reduced acquisition and reconstruction time for screening purposes. We introduce inline acquisition and reconstruction architecture to obtain in real time the 3D attenuation map of the animal fulfilling the three previous requirements. The micro-CT system is based on commercially available x-ray detector and micro-focus x-ray source. The reconstruction architecture is based on a cluster of PCs where a dedicated communication scheme combining serial and parallel treatments is implemented. In order to obtain high performance transmission rate between the detector and the reconstruction architecture, a dedicated data acquisition system is also developed. With the proposed solution, the time required to filter and backproject a projection of 2048 x 2048 pixels inside a volume of 140 mega voxels using the Feldkamp algorithm is similar to 500 ms, the time needed to acquire the same projection.

1 June 2018 in Annales de Chirurgie Plastique Esthétique
Verified
Journal Article
Closed access
TMT. Muller
T. Muller
ABA. Baratte
A. Baratte
CBC. Bruant-Rodier
C. Bruant-Rodier
FBF. Bodin
F. Bodin
CMCAROLE MATHELIN
CAROLE MATHELIN

4 October 2021 in European Journal of Breast Health
Verified
Journal Article
Closed access
PIPaul Ionescu
Paul Ionescu
FVFlorence Vibert
Florence Vibert
SAShanti Amé
Shanti Amé
CMCAROLE MATHELIN
CAROLE MATHELIN
This study aimed to illustrate the epidemiological situation of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) by focusing on the changes published after 2019 and particularly the new approaches of cosmetic and reconstructive breast surgery. Article search was performed from January 2019 to date using the PubMed database. Fourteen articles were included in the qualitative evaluation of international data. Moreover, the latest reports regarding the total number of BIA-ALCL cases and number of deaths were identified. Estimates of the risk and incidence have increased significantly recently, affecting 1 in every 2,969 women with breast implants and 1 in 355 patients with textured implants after breast reconstruction. The average exposure time to diagnosis was 8 (range: 0–34) years. Approximately 80% of BIA-ALCL cases were diagnosed at IA–IIA stages, for which the treatment was breast implant removal, full capsulectomy, and excision of all suspected lymph nodes. Globally, at least 949 cases were reported to date. At present, BIA-ALCL is an emerging pathology of interest. Data collection initiated since 2016 through different case registration databases is essential to ensure surveillance and to continue to increase the number of studies on this recently discovered pathology.